Tan Thean Yen, Ng Lily Siew Yong, Kwang Lee Ling, Rao Suma, Eng Li Ching
Department of Laboratory Medicine, Changi General Hospital, 2 Simei Street 3, 529889, Singapore.
Department of Laboratory Medicine, Changi General Hospital, 2 Simei Street 3, 529889, Singapore.
Anaerobe. 2017 Feb;43:69-74. doi: 10.1016/j.anaerobe.2016.11.009. Epub 2016 Nov 25.
This study investigated the clinical features of anaerobic bacteraemia in an acute-care hospital, and evaluated the antimicrobial susceptibility of these isolates to commonly available antibiotics. Microbiological and epidemiological data from 2009 to 2011were extracted from the laboratory information system and electronic medical records. One hundred and eleven unique patient episodes consisting of 116 anaerobic isolates were selected for clinical review and antibiotic susceptibility testing. Susceptibilities to amoxicillin-clavulanate, clindamycin, imipenem, metronidazole, moxifloxacin, penicillin and piperacillin-tazobactam were performed using Etest strips with categorical interpretations according to current CLSI breakpoints. Metronidazole-resistant and carbapenem-resistant anaerobic Gram-negative bacilli were screened for the nim and cfiA genes. Clinical data was obtained retrospectively from electronic medical records. During the 3 year period, Bacteroides fragilis group (41%), Clostridium species (14%), Propionibacterium species (9%) and Fusobacterium species (6%) were the most commonly isolated anaerobes. Patients with anaerobic bacteraemia that were included in the study were predominantly above 60 years of age, with community-acquired infections. The most commonly used empiric antibiotic therapies were beta-lactam/beta-lactamase inhibitor combinations (44%) and metronidazole (10%). The crude mortality was 25%, and appropriate initial antibiotic therapy was not significantly associated with improved survival. Intra-abdominal infections (39%) and soft-tissue infections (33%) accounted for nearly three-quarters of all bacteraemia. Antibiotics with the best anaerobic activity were imipenem, piperacillin-tazobactam, amoxicillin-clavulanate and metronidazole, with in-vitro susceptibility rates of 95%, 95%, 94% and 92% respectively. Susceptibilities to penicillin (31%), clindamycin (60%) and moxifloxacin (84%) were more variable. Two multidrug-resistant isolates of Bacteroides species were positive for nim and cfiA genes respectively, while another two imipenem-resistant Fusobacterium species were negative for cfiA genes. This study demonstrated that anaerobic bacteraemia in our patient population was predominantly associated with intra-abdominal and soft-tissue infections. Overall antibiotic resistance was high for penicillin and clindamycin, and the presence of emerging resistance to carbapenems and metronidazole warrants further monitoring.
本研究调查了一家急症医院中厌氧菌血症的临床特征,并评估了这些分离株对常用抗生素的药敏性。从实验室信息系统和电子病历中提取了2009年至2011年的微生物学和流行病学数据。选择了111例包含116株厌氧分离株的独特患者病例进行临床复查和抗生素药敏试验。使用Etest试纸条按照当前CLSI标准进行阿莫西林-克拉维酸、克林霉素、亚胺培南、甲硝唑、莫西沙星、青霉素和哌拉西林-他唑巴坦的药敏试验,并进行分类解读。对耐甲硝唑和耐碳青霉烯的厌氧革兰氏阴性杆菌进行nim和cfiA基因筛查。临床数据从电子病历中回顾性获取。在这3年期间,脆弱拟杆菌属(41%)、梭菌属(14%)、丙酸杆菌属(9%)和梭杆菌属(6%)是最常分离出的厌氧菌。纳入本研究的厌氧菌血症患者主要为60岁以上,感染为社区获得性。最常用的经验性抗生素治疗是β-内酰胺/β-内酰胺酶抑制剂联合用药(44%)和甲硝唑(10%)。粗死亡率为25%,适当的初始抗生素治疗与生存率的提高无显著相关性。腹腔内感染(39%)和软组织感染(33%)占所有菌血症的近四分之三。对厌氧菌活性最佳的抗生素是亚胺培南、哌拉西林-他唑巴坦、阿莫西林-克拉维酸和甲硝唑,体外药敏率分别为95%、95%、94%和92%。对青霉素(31%)、克林霉素(60%)和莫西沙星(84%)的药敏性差异更大。两株多药耐药的拟杆菌属分离株分别对nim和cfiA基因呈阳性,而另外两株耐亚胺培南的梭杆菌属分离株对cfiA基因呈阴性。本研究表明,我们患者群体中的厌氧菌血症主要与腹腔内和软组织感染相关。青霉素和克林霉素的总体耐药率较高,对碳青霉烯类和甲硝唑出现的耐药性值得进一步监测。